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ABSTRACT  
Objective: To evaluate the effect of binder concentration, granule size and distance between punches on mechanical strength and drug release 
properties of tablets containing Malva verticillata mucilage (MVM) as a binder. 
Methods: Paracetamol and lactose were converted into wet coherent masses by a liquid solution containing 1-3% w/w MVM as a binder. Granules 
containing 2% w/w binder was used to investigate the effect of granule size and distance between punches. Compressed tablets were evaluated for 
crushing strength, disintegration time and in vitro drug release using pharmacopeial methods. 
Results: Granules containing MVM were found to be free-flowing and compatible with paracetamol. Mechanical strength and drug release 
properties of mucilage tablets significantly correlated with the amount of MVM binder. Tablet crushing strength was 3.54-7.12 kg/cm2 while 
disintegration time 7.13-16.67 min. Compression pressure and granule size had no significant effects on drug release properties of mucilage tablets. 
Crushing strength of mucilage tablets were higher and significantly different (t(26) = 7.9631, p
Conclusion: Properties of tablets containing 2.5% w/w MVM matched the prescribed pharmaceutical limits and hence M. verticillata root mucilage 
has a great potential to become a new source of tablet binder.  
<0.05) from acacia tablets in the tested variables. The 
cumulative drug release rate of mucilage tablets was also lower than that of acacia tablets in tested concentrations. 
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Tablets remain one of the most important dosage forms of 
presenting pharmacologically active ingredients. Common problems 
encountered during manufacturing and use of tablets include 
incompatibility, poor flow, mechanical strength and poor drug 
release rates [1, 2]. Incompatibility due to chemical and 
intergranulate interactions compromises stability, efficacious and 
viability of drug content. Also, the type and amount of binder, 
granules size and compression pressure influence mechanical 
strength and bioavailability of the formulated tablet. This calls for 
optimization of stated variables in order to strike a balance between 
the properties of compressed tablets.  
Binders are included in a tablet formulation to improve granule flow, 
promote cohesiveness and strengthen intra-granular bonds. High 
concentration of binder leads to the formation of stronger tablets but 
with poor drug release rates [3]. The choice of a binder depends on 
compatibility with other ingredients, ability to improve mechanical 
strength and release of the drug to achieve its intended purposes [1, 4, 
5]. Properties of aggregates and tablets vary with granule size [6]. It 
was earlier reported that decrease in granule size before compression 
corresponds to an increase in tablet strength [7], however, it has since 
been established that there is no correlation [8, 9]. The magnitude of 
com
Mucilage obtained from a number of plant species have been 
evaluated as tablet binders, thickening agents and as the polymer in 
sustained release tablets [10, 13-15]. However, these efforts have 
yielded few potential tablet binders with some being reported to 
demonstrate inferior performance as compared to the commercially 
available binders [15]. 
pression force affects deformation of granules which subsequently 
alter tablet hardness and disintegration time with or without 
significant effect on dissolution rate [10-12]. 
Malva verticillata L. (Cluster mallow, Malvaceae) is often used as a 
vegetable and as a herb in traditional medicine. The plant grows as a 
herb with alternate leaves that have five to seven lobes. It is an 
annual plant that grows in well-drained moist soil with moderate 
fertility into variable size ranging from low lying to 1.7 m tall [16, 
17]. The roots of M. verticillata when peeled or soaked in water 
releases a sticky slippery fluid which can be exploited as a tablet 
binder. The aim of this study was to optimize the potential of MVM 
as a tablet binder by assessing the effect of binder concentration, 
granule size and distance between punches on the in vitro properties 
of the formulated tablets.  
MATERIALS AND METHODS  
Paracetamol IP, lactose BP, acacia gum BP, talc and magnesium 
stearate were sourced from the pharmaceutical manufacturing 
company. Other reagents used were of analytical grade. M. 
verticillata roots were collected from Eastlands, Nairobi County-
Kenya, after authentication by a taxonomist. Sample specimen was 
preserved at The University of Nairobi herbarium, voucher number, 
PCK2015/01.  
Extraction and purification of mucilage 
Air dried root bark of M. verticillata was grounded into 250-500 µm 
size particles. These were then pre-treated with 95% ethanol in a 
boiling-water bath for 1 h to remove pigments and organic 
compounds. Distilled water containing 1% sodium metasulphite was 
added to the pre-treated root bark at the ratio of 20:1 (ml/g) and 
stirred regularly at 50 °C for 3 h to arrest oxidation, microbial 
growth and enzymatic activity. The mixture was strained through a 
fourfold muslin cloth and centrifuged at 3000 rpm for 10 min to 
remove fine insoluble fibre. The supernatant was deprotonated with 
a mixture of chloroform and n-butanol (4:1 v/v) in a boiling water 
bath for 10 min to remove soluble proteins. The resulting filtrate 
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was then mixed with 95% ethanol at equal volumes to dissolve the 
mucilage. The obtained mucilage was then dried at 45 °C in an oven 
dryer, grounded and passed through British standard sieve (BSS) no. 
60 (250 µm) before storing in airtight bags at room temperature.  
Preparation of granules 
The model drug (paracetamol) and diluent (lactose) were 
homogenously dry-mixed in a pestle and mortar. This blend was 
converted into a wet coherent mass by adding 15 ml of a liquid 
suspension containing 1.0 to 3.0 % w/w
 
 of tablet binder (table 1). 
The wet mass was forced through a BSS no.18 (1000 µm), dried in a 
hot air oven at 50 ˚C to obtain granules with a moisture content 
below 2.9 % w/w. These were then mixed with 1 % talc as an internal 
lubricant and stored in airtight bags. The lubricant was added after 
granulation as wet lubricants interfere with the disintegration of tablets. 
In this study, disintegrants were not included in the formulations. 
Table 1: Formulation of tablets with different amounts of binder 
% w/w of binder 
per tablet 
Tablet ingredients 
Binder (mg) Paracetamol (mg) model drug Lactose (mg) diluents Talc (mg) lubricant Tablet weight (mg) 
1.0 3.0 250 44.0 3.0 300 
1.5 4.5 250 42.5 3.0 300 
2.0 6.0 250 41.0 3.0 300 
2.5 7.5 250 39.5 3.0 300 
3.0 9.0 250 38.0 3.0 300 
 
Compression of granules  
Granules containing 1.0 to 3.0 % w/w binder
Evaluation of granules  
 were passed through 
BSS no. 25 (710 µm) and compacted into 300 mg circular tablet by a 
single punch press and stored over silica gel, to allow for elastic 
recovery. Granules containing 2% w/w binder were divided into two 
portions. The first portion was shaken through a nest of sieves to 
give three fractions viz. 149–250 µm, 250–500 µm and 500–707 µm. 
Each fraction was compacted at fixed amplitudes between punches. 
The second portion was passed through BSS no. 25 and compacted 
at different amplitudes (3-5 cm) between punches. Above procedure 
was repeated using acacia gum (ACG) as the standard binder.  
Bulk density, Tap density, Hausner’s ratio and Carr’s index  
Granules (149-707 µm) weighing 20 g and containing 1.0 to 3.0 % 
w/w MVM was transferred into 50 ml graduated cylinder and 
tapped at a height of 5 × 10-2m from the bench. The volume was 
noted after three tapings and also at equilibrium (constant volume). 
Bulk density (Db) and tap density (Dt) were determined based on 
the three tapings and at equilibrium. Flow properties and 
cohesiveness of mucilage granules were determined by Hausner 
index (Dt/Db) and Compressibility index (1-Db/Dt
Angle of repose  
) 100 [18]. 
Granules (149-707 µm) weighing 20 g were allowed to flow through 
a funnel to form a heap that just touched the tip of the funnel. The 
height of the heap (h) and the diameter of the base (D
(θ) = tan
) were used to 
calculate the Angle of repose (θ) [19]. 
-1 2hD
Strength of granules  
-1 
Granules (0.250-0.707 μm) weighing 6.5 g were run for 100 
revolutions in a friabilitator and sieved through a 60-mesh screen. 
The oversize granules were weighed and strength of granules 
determined [20]. 
% strength of granules = (weight of granules–oversize 
weight/weight of granules) × 100 
Drug-excipient compatibility  
A portion of the sample weighing 100 mg was mixed with KBr and 
compressed into discs by applying pressure of 5 tons for 5 min in a 
hydraulic press. The pellet was placed in the light path and the IR spectra 
of MVM, paracetamol and granules mixture were obtained and 
compared to check for interaction, shift or loss of functional peaks [13].  
Evaluation of tablets  
Crushing strength  
One tablet at time (n = 6) was placed in between the jaw of 
Monsanto hardness tester and force required to diametrically break 
the tablet was determined. 
Friability  
Twenty tablets were rotated 100 times in a Roche friabilator ®. 
Tablets were then removed dusted, weighed and friability calculated 
as percentage weight loss [20]. 
Disintegration time 
One tablet was placed into each of the six tubes of disintegration 
apparatus (Model ED-2 Electrolab, Mumbai) and suspended in 900 
ml of 0.1M HCl medium at 37±1 °C. The time taken by each tablet to 
break into small particles was noted [21]. 
Dissolution rate 
The Paraceta mol in vitro release profiles were determined in 900 ml 
phosphate buffer (pH 5.8) at 37±1 °C using basket apparatus no. 2
Evaluation of in vitro properties  
 at 
50 rpm. 10 ml samples were drawn after 5 min and subsequently 
after every 10 min for 1 h. The samples were filtered, diluted and the 
absorbance determined at 243 nm. Amount of drawn sample was 
replaced by equivalent volume of buffer solution [21]. 
Tablet in vitro properties are usually evaluated using variables that 
include crushing strength (CS), friability ratio (FR) and disintegration 
time (DT). The in vitro properties evaluated were mechanical strength 
and drug release. Crushing strength-friability ratio (CS/FR) was used 
to evaluate mechanical strength of tablets while drug release was 
measured by CS/FR: DT ratio. Stronger tablets have higher CS/FR ratio 
while high CS/FR: DT ratio indicates a better balance between 
mechanical strength and disintegration properties of tablets [22]. 
Data analysis  
Multivariate analysis including analysis of variance (ANOVA), 
correlation, regression and t-test were used to test for significant 
effect of binder concentration, granule size and distance between 
punches on mechanical and drug release properties of tablets. 
Graphs were plotted in Microsoft Excel and data analyzed by IBM 
SPSS. All values were expressed as mean±SD. Values of P<0.05 and 
P<0.01 were considered to be statistically significant.  
RESULTS AND DISCUSSION  
Properties of granules  
The decrease in bulk and tap density with increase in the amount of 
mucilage (table 2), indicated the capability of MVM to enlarge granules 
and concentrate binding bridges. High values of tap density showed 
the existence of particle attraction and interlocking property. The 
registered CI (<15 %) and HI (<1.25) values in all formulations 
signified that mucilage granules were cohesive, free-flowing, 
compressible and possessed desirable packing characteristics (table 
2). The significant difference in granule flow between 2.5 % and 3 % 
w/w mucilage formulations was due to increase in density and 
saturation of the binding forces [23]. The angle of repose was less than 
30° within the tested formulations. This illustrated good flow and 
uniform distribution of bridging forces [19]. Decrease in percentage 
Int J Pharm Pharm Sci, Vol 10, Issue 6, 26-31 
28 
friability and fines with an increase in binder concentration (table 2) 
signified capability of the mucilage to bind particles and form granules 
with satisfactory properties.
  
 The observed negative correlations (r<1) 
with the micrometric properties and mucilage concentration showed 
that densification, ability to flow and cohesiveness of the granules 
were dependent on mucilage concentration. 
Table 2: Micrometric properties of granules vs. amount of MVM 
Binder Bulk density (g/ml) Tap density (g/ml) Hausner’s index Compressibility index (%) Angle of repose (Ө) % Friability 
1.0 0.665±0.006 0.770±0.002 1.160±0.008 13.70±0.006 27.32±1.52 19.42±0.5 
1.5 0.651±0.005 0.740±0.004 1.142±0.002 12.46±0.002 27.52±1.01 18.75±0.12 
2.0 0.628±0.003 0.712±0.004 1.130±0.002 12.46±0.002 28.35±1.08 18.41±0.5 
2.5 0.620±0.003 0.690±0.007 1.123±0.007 11.79±0.006 30.19±0.64 18.13±0.3 
3.0 0.602±0.007 0.655±0.007 1.088±0.003 10.96±0.003 29.55±0.59 17.24±0.7 
n=3, data presented as mean±SD and p<0.01 
 
Drug-mucilage compatibility 
M. verticillata mucilage was found to be compatible with paracetamol 
because all individual characteristic and functional vibrational peaks 
associated with the active principle were observed in the FTIR spectra 
of granules mixture (fig. 1). The observable functional peaks include O-
H, N-H, C=O and C-N stretching bands at 3326.98, 3413.77, 1654.81 
and 1259.43 cm-1
 
 respectively. Decrease in IR absorption intensity of 
hydroxyl functional group of paracetamol in the granule mixture 
illustrates the possibility of formation of hydrogen bonds [13, 24]. 
Absence of peak shifting and retention of functional peaks indicated 
that there was no chemical interaction in the mixture. 
 
Fig. 1: FTIR spectrum of granule mixture 
 
Mechanical strength of tablets 
Effect of the amount of MVM and ACG on the mechanical strength 
of tablets are presented in table 3 below. Friability was observed 
to decrease with increase in the concentration of binder. During 
the test, none of the tablets cracked, peeled or smashed. This 
indicated the potential of MVM and ACG to enhance formation of 
adhesive bridges which resist abrasion, shock and capping 
tendencies, common with substances which undergoing 
fragmentation [25].  
The significant correlation (r>1, P<0.01) between the amount of 
mucilage and crushing strength, signifies ability of MVM to form a 
thick mucilaginous film which contributes to tablet strength [26]. 
Increase in mucilage concentration by 1.0% w/w had a significant 
effect (p>0.05) on the hardness of tablets. This indicated that the 
binding potential of MVM
Mechanical strength of the tablets obtained from mucilage 
formulation was found to be superior to those of acacia gum at 2-3% 
w/w concentration as depicted by high CS/FR ratio [22]. This was 
supported by high regression coefficient of 1.78 in MVM as 
compared to 1.43 of acacia tablets. Tablets containing 1% w/w 
mucilage were weaker than corresponding acacia tablets because of 
high bulk density which reduces space for deformation while ACG 
increases packing per unit space [27]. 
 was concentration-dependent.  
  
Table 3: Mechanical strength of tablets containing different amount of binders 
Binder concentration (% w/w) Crushing strength (kg/cm2 Friability (%) ) Crushing strength-friability ratio (CS/FR) 
MVM ACG MVM ACG MVM ACG 
 1.0 3.54±0.27 3.58±0.34 0.86±0.01 0.66±0.04 4.12±0.30 5.38±0.166 
1.5 5.07±0.14 4.18±0.16 0.55±0.01 0.54±0.02 9.16±0.14 7.708±0.21 
2.0 6.15±0.06 5.12±0.04 0.51±0.02 0.435±0.03 12.07±0.42 11.81±0.69 
2.5 6.78±0.25 5.94±0.33 0.38±0.01 0.42±0.02 17.85±0.20 14.80±0.67 
3.0 7.12±0.21 6.26±0.25 0.35±0.03 0.33±0.01 17.0±0.25 15.67±0.59 
n=3, data presented as mean±±SD, p<0.05). 
 
Fig. 2 below shows the effect of increasing distance between punches 
on mechanical properties of tablets. The significant correlation (r˃1, 
p<0.01) between CSFR and distance between punches shows that 
increasing distance between punches results in tablets with high 
mechanical strength. This could be due to gas displacement and closer 
particle-particle interaction leading to the formation of strong bonds 
[11]. However, increasing distance between punches did not have any 
significant (F (4, 10) =3.307, P=0.123) effect on tablet hardness. 
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Fig. 2: Effect of distance between punches on the mechanical 
strength of tablets containing 2.0% w/w M. verticillata mucilage 
and acacia gum as a binder, mean±SD, n=3, p<0.01. ACG-CSFR and 
MVM-CSFR is the crushing strength-friability ratio of tablets 
containing acacia gum and M. verticillata mucilage as tablet binder, 
respectively 
 
Fig. 3a below shows that crushing strength decreased significantly (F(4, 
10) =405.475, P<0.05) with an increase in granule size. Tablets 
obtained from the initial granule mixture (149-707 µm) were stronger 
than those obtained from 500-707 µm. This was due to wider particle 
size distribution, better packing rearrangement and extra adhesive 
bridges by fines in void spaces. Small sized granules (149-250 µm) on 
compression yielded stronger tablets as they packed well and had a 
larger surface area which contributed to the formation of strong inter-
particulate bonding. Larger sized granules (500-707 µm) have smaller 
surface area and high void spaces resulting information weak inter-
particulate bonds in compressed tablets [28]. Lack of fragmentation of 
the large mucilage granules resulted in to weaker tablets [8]. Analysis 
of the result shows the insignificant difference (p˃0.01) between 
mechanical strength of MVM and ACG tablets obtained from 
compressing granules of different size (fig. 3b).  
 
 
Fig. 3a: Effect of granule size on crushing strength of tablets, 
mean±SD, n=3, p˂0.05 ACG-CS and MVM-CS is crushing strength 
of tablets containing acacia gum and M. verticillata mucilage, 
respectively 
 
Fig. 3b: Effect of granule size on the mechanical strength of 
tablets, mean±SD, n=3, p˂0.01 ACG-CSFR and MVM-CSFR is the 
mechanical strength-friability ratio of tablets containing acacia 
gum and M. verticillata mucilage, respectively 
 
Results in table 3, fig. 2 and 3 above, showed that mechanical 
properties of mucilage tablets in all tested variables; concentration, 
granule size and distance between punches were high and 
significantly different from those of acacia tablets (t26 = 
7.963, p
3211 83.076.179.103.6 XXXY +−+=
<0.05). The following model equation was used to indicate 
that tablet hardness increased significantly with a decrease in 
granule size, increase in the concentration of mucilage and increase 
in distance between punches.  
 
Where Y1 is hardness in kg/cm2, X1 is mucilage concentration (% 
w/w), X2 is granule size in µm and X3 is the distance between 
punches in cm. The negative coefficient (-1.760) signified that 
crushing strength decreased significantly (p<0.05) with an increase 
in granule size. The high correlation coefficient (1.79) indicated that 
binding potential of MVM was concentration-dependent. A low 
coefficient of X3 
Disintegration time 
implied the insignificant effect of distance between 
punches. 
Table 4 below shows the effect of increasing concentration of binder 
on the time of disintegration. The significant correlation (p<0.05) 
between the concentration of MVM and disintegration time was due 
to the formation of a mucilaginous viscous film which hindered 
penetration of water thus preventing disintegration [11]. This effect 
was more pronounced in tablets containing 3% w/w mucilage that 
disintegrated after 16 min which is above the phermocopial limit of 
≤15 min [29]. This observation showed that mucilage at high 
concentration has strong binding properties which may hinder 
disintegration. Regression analysis showed that hardness of tablets 
had less influence on disintegration time than the amount of binder. 
 
Table 4: Disintegration time for tablets containing different amount of MVM and ACG as tablet binder 
Binder concentration (% 
w/w) 
Disintegration time (min) CSFR: DT 
MVM ACG MVM ACG 
1.0 7.13±0.51 3.35±0.13 0.58±.006 1.61±0.02 
1.5 9.23±0.28 4.52±0.06 0.94±0.03 1.76±0.05 
2.0 12.17±0.53 5.71±0.57 1.0±0.04 1.23±0.07 
2.5 14.80±0.48 7.15±0.13 1.21±0.05 1.94±0.08 
3.0 16.67±0.59 7.35±0.20 0.97±0.01 1.84±0.15 
n=3, data presented as mean±SD, p<0.05). 
 
Fig. 4a below shows the effect of granule size on disintegration 
time of tablets. The negative correlation (r<1, p<0.01) between 
disintegration time and tablets obtained by compressing 
granules of different sizes suggested that disintegration time 
decreased with increase in granule size. Large granules in the 
size range 500-700 µm disintegrated faster than small sized 
granules. This could be explained in terms of porosity. Large 
granules form strong pores which do not collapse during 
compression while small sized granules of less than 250 µm form 
collapsible pores. Small pores reduce penetration and hence 
increase disintegration time. Earlier studies attributed 
disintegration to swelling and creation of other active 
disintegration mechanisms [26]. The poor disintegration of 
tablets obtained from the initial granule mixture (149-707 µm) 
may have been due to particle size distribution, hindered 
penetration and strong binding contributed by fines. However, 
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granule size was found to have no significant effect on drug 
release properties as shown by CSFR/DT values (fig. 4b).  
 
Fig. 4a: Effect of granule size on disintegration time of tablets, 
mean±SD, n=3, p˂0.01 ACG-DT disintegration time of tablets 
containing acacia gum and M. verticillata mucilage, respectively 
 
 
Fig. 4b: Effect of granule size on drug release properties of 
tablets, mean±SD, n=3, p˂0.01 ACG-CSFR-DT is the crushing 
strength-friability, disintegration time ratio of tablets 
containing acacia gum and M. verticillata mucilage, respectively 
 
Fig. 5 below shows the insignificant correlation (r ˃1, p˃0.01) 
between the effects of increasing distance between punches on 
disintegration time. Wider distance between punches brings 
particles closer to each other resulting in a reduction in tablet 
porosity and hence increase in disintegration time. 
 
 
Fig. 5: Effect of pressure on drug release properties of tablets 
containing M. verticillata mucilage and acacia gum as tablet 
binder, mean±SD, n=3, p<0.01. AGM-CSFR: DT and MVM-CSFR: 
DT is the Crushing strength-friability, disintegration time ratio 
of tablets containing 2.0% w/w of acacia gum and M. verticillata 
mucilage as tablet binder respectively 
 
Results in table 4, fig. 4 and 5 above shows that mucilage tablets 
were less superior and significantly different at all tested variables 
from those of acacia tablets (t 14 =-39.925, p
3212 29.204.377.418.13 XXXY +−+=
<0.05). This was 
revealed by low values of CSFR: DT. The negative coefficient 
indicated that mucilage retarded disintegration time more than 
acacia gum. Decreasing granule size while increasing MVM 
concentration and distance between punches hindered 
disintegration thus increasing tablet disintegration time as shown by 
the following model equation.  
 
Where Y2 is disintegration time in minutes, X1 is s concentration of 
mucilage (% w/w), X2 is granule size in microns and X3 
DISSOLUTION 
is the distance 
between punches. High coefficient of concentration (4.77) indicates that 
it has more influence on disintegration time than other tested variables. 
The peak CS/FR: DT values for mucilage tablets was recorded at 2.5% 
w/w, 149-707 µm granule size and when compressed at low pressure 
(table 4, fig. 4 and 5). This observation are indicative of the optimum 
conditions for the formulation of mucilage tablets.  
Fig. 6 illustrates the cumulative amount of drug release against 
time for tablets containing 2.0 and 3.0% w/w MVM and ACG as a 
binder. The positive correlation (r>0.947) between the amount of 
drug released and time indicated a constant drug release. The 
gradient of the curves with a dipping slope at the initial stage was 
an indication of the ability of tablets to boost and maintain 
constant drug concentration in vivo. High dissolution rate of ACG 
tablets was through the enhancement of drug solubility [28]. Low 
release rate of mucilage tablets was due to hydration which leads 
to the formation of the mucilaginous and sticky film. The viscosity 
of the film and diffusional path length determines the release rate 
[12]. Cumulative amount of 68.94% for tablets containing 3.0% 
w/w
 
 mucilage at the end of 30 min was below the Pharmacopeial 
limit (>80% after 30 min) and is an indication of tablet with 
slower release rates.  
 
Fig. 6: Cumulative percentage of drug release Vs. time of tablets 
containing 2.0 and 3.0 % w/w M. verticillata mucilage and 
acacia gum as tablet binder, n=3 and p<0.01, ACG-2 and ACG-3 
tablet containing g 2.0 and 3.0 % w/w acacia gum as tablet 
binder, MVM-2 and MVM-3 tablet containing g 2.0 and 3.0 % 
w/w M. verticillata mucilage as tablet binder 
 
CONCLUSION 
The in vitro properties of mucilage tablets varied in all the tested 
variables. M. verticillata mucilage is compatible with paracetamol 
and has the capability to improve granule flow. Small sized 
granules when compressed at high-pressure yields tablets with 
high mechanical strength and poor drug release properties. 
Compression pressure and granule size were found to have no 
significant effect on drug release properties of MVM tablets. 
Granules in the size range of 149-707 µm containing 2.0% w/w 
mucilage yield tablets with good mechanical strength and drug 
release rate properties comparable with those of acacia gum. This 
study has shown that M. verticillata mucilage at a higher 
concentration can be exploited as a binder in the formulation of 
slow release and mucoadhesive tablets.  
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